Molecular characterization of novel trispecific ErbB-cMet-IGF1R antibodies and their antigen-binding properties

por Castoldi, R., Jucknischke, U., Pradel, L.P., Arnold, E., Klein, C., Scheiblich, S., Niederfellner, G., Sustmann, C.
Publicado 2012

P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour model

por Kobold, S, Steffen, J, Grassmann, S, Castoldi, R, Schmollinger, J, Sustmann, C, Nierderfellner, G, Klein, C, Bourquin, C, Endres, S
Publicado 2014

A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity

por Castoldi, R, Ecker, V, Wiehle, L, Majety, M, Busl-Schuller, R, Asmussen, M, Nopora, A, Jucknischke, U, Osl, F, Kobold, S, Scheuer, W, Venturi, M, Klein, C, Niederfellner, G, Sustmann, C
Publicado 2013